arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Alaunos Therapeutics, Inc.

TCRT

$1.97 ▼ -0.03 (-1.50%) at close

23 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Alaunos Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.8M

Dividend Yield —

Revenue Growth -50.0% ↘

Op. Margin None

ROIC -155.0% ↗

FCF / Share $-1.52 ↗

Trailing P/E —

Price / Book 2.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

23-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.00K

↓ -50.0% —

Net Income Profit after all expenses

$-4.18M

↑ +10.8% —

FCF / Share Free cash flow per share

$-1.52

↑ +50.9% —

Long-Term Debt Long-term obligations

$0.00

— —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Sep 9, 2003 10-K ↗
Revenue Growth YoY (%)	-50.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-725%)	100.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	-99.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1348%)	634.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7827%)	—	—	—	-99.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1339%)	131.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1547%)	—	—	—	—	119.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1399%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	24.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-32.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	15.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	-605.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	N/M	N/M	59.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	10.8% Fair ↓ Fair Declining Year-over-year change in net income	86.7% Excellent ↑ Excellent Improving Year-over-year change in net income	6.9% Fair ↓ Fair Declining Year-over-year change in net income	52.1% Excellent ↑ Excellent Improving Year-over-year change in net income	1.5% Caution ↑ Caution Improving Year-over-year change in net income	32.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-121.8% Weak ↓ Weak Declining Year-over-year change in net income	2.2% Caution ↑ Caution Improving Year-over-year change in net income	67.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-37.6% Weak ↑ Weak Improving Year-over-year change in net income	-277.9% Weak ↓ Weak Declining Year-over-year change in net income	90.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-20.1% Weak ↑ Weak Improving Year-over-year change in net income	-344.9% Weak ↓ Weak Declining Year-over-year change in net income	-95.2% Weak ↓ Weak Declining Year-over-year change in net income	-327.1% Weak ↓ Weak Declining Year-over-year change in net income	69.7% Excellent ↑ Excellent Improving Year-over-year change in net income	5.2% Fair ↑ Fair Improving Year-over-year change in net income	-49.0% Weak ↑ Weak Improving Year-over-year change in net income	-16.2% Weak Weak Year-over-year change in net income	-170.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	50.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-63.7% Weak ↑ Weak Improving Year-over-year change in free cash flow	6.8% Fair ↑ Fair Improving Year-over-year change in free cash flow	-573.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	5.1% Fair ↑ Fair Improving Year-over-year change in free cash flow	-30.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	29.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	14.0% Fair Fair Year-over-year change in free cash flow	10.4% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-88.0% Weak Weak Compound annual revenue growth over 3 years	-70.7% Weak Weak Compound annual revenue growth over 3 years	—	—	39.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	-49.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-28.7% Weak Weak Compound annual revenue growth over 5 years	-43.4% Weak Weak Compound annual revenue growth over 5 years	—	—	—	61.1% Excellent Excellent Compound annual revenue growth over 5 years	59.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Sep 9, 2003 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	-336.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2343%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	-341.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2947%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	-348.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Sep 9, 2003 10-K ↗
Return on Invested Capital (%)	-155.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-184.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-429.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-71.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	43.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	168.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-108.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-101.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-571.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-487.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-78.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-63.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-34.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	-142.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-174.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-414.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-81.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-53.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-56.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-78.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-96.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-497.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-358.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-39.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-194.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1393%)	-226.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1612%)	—	-97.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-752%)	-135.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1004%)	-64.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-530%)	-124.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-927%)	-62.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-514%)	56.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+274%)	213.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1326%)	-137.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1016%)	-93.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-726%)	—	—	-89.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-694%)	-106.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-813%)	-27.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	—	-87.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-684%)	-67.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-549%)	-213.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1522%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Sep 9, 2003 10-K ↗
Debt to Equity (x)	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.28x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-53%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	-17.84x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.13x Weak Weak Operating income divided by interest expense Optimal: > 5x	-65.22x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-1.39M	$-1.09M	$-6.06M	$-39.06M	$-59.80M	$-115.07M	$-79.74M	$-61.73M	$-70.95M	$-81.05M	$-140.72M	$-42.80M	$-68.20M	$-73.31M	$-104.71M	$-60.39M	$-48.84M	$-11.38M	—	—	—	—	$0.00
Debt / EBITDA (x)	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.22x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Sep 9, 2003 10-K ↗
Revenue per Share (USD)	$0.00	$0.01	$0.00	$0.20	$0.00	$0.00	—	$0.00	$0.12	$0.05	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-2.20	$-2.92	$-2.20	$-2.61	$-0.37	—	$-0.70	$0.96	$-0.53	$-1.32	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.52	$-3.10	$-1.90	$-2.03	$-0.30	$-0.32	$-0.24	$-0.35	$-0.40	$-0.45	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.92	$1.29	$0.39	$2.41	$0.27	$0.58	$0.52	$0.53	$-0.68	$-0.59	$0.66	$0.32	$0.49	$0.58	$1.03	$0.63	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.92	$1.29	$0.39	$2.41	$0.27	$0.58	$0.52	$0.53	$-0.68	$-0.59	$0.66	$0.32	$0.49	$0.58	$1.03	$0.63	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	1.95M	1.60M	16.00M	14.48M	214.40M	209.64M	167.95M	143.51M	136.94M	130.39M	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Sep 9, 2003 10-K ↗
Working Capital (USD)	$1.18M	$2.06M	$6.30M	$29.63M	$62.79M	$112.22M	$92.97M	$74.80M	$69.93M	—	$134.40M	$33.26M	$62.51M	$61.41M	$92.74M	$57.20M	—	—	—	—	—	—	—
LT Debt (USD)	—	—	$0.00	$0.00	$16.25M	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$2.15M	$2.06M	$6.31M	$38.55M	$58.06M	$123.98M	$95.01M	$85.56M	$-96.81M	$-77.30M	$87.37M	$33.84M	$49.38M	$48.45M	$71.61M	$30.55M	$28.10M	$6.74M	$30.37M	$26.53M	$7.20M	$-144.00K	$500.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Sep 9, 2003 10-K ↗
Sales/Revenue/Turnover (USD)	$5.00K	$10.00K	$5.00K	$2.92M	$398.00K	$0.00	—	$146.00K	$15.90M	$6.86M	—	—	—	$1.47M	$667.00K	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$7.00K	$2.00K	$2.31M	$2.76M	$2.60M	$1.13M	$629.00K	$575.00K	$369.00K	$290.00K	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-4.18M	$-4.68M	$-35.14M	$-37.73M	$-78.75M	$-79.98M	$-117.80M	$-53.12M	$-54.32M	$-165.30M	$-120.09M	$-31.78M	$-340.83M	$-283.72M	$-63.78M	$-32.67M	$-7.65M	$-25.23M	$-26.61M	$-17.86M	$-15.36M	$-5.69M	—
Operating Cash Flow (USD)	$-2.87M	$-4.97M	$-30.14M	$-29.23M	$-61.47M	$-57.01M	$-40.85M	$-49.46M	$-54.67M	$-58.33M	—	—	$-281.15M	$-221.64M	$-38.84M	$-19.69M	$-12.29M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 23 years · 73 quarters

Alaunos Therapeutics, Inc.

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TCRT with peers